New cancer drug AP601 enters first human safety tests
Disease control
Recruiting now
This early-stage study tests a new drug called AP601 in people with advanced solid tumors that have not responded to standard treatments. The main goal is to find the highest safe dose and check for side effects. About 36 participants will receive different doses based on body we…
Phase: PHASE1 • Sponsor: AP Biosciences Inc. • Aim: Disease control
Last updated May 17, 2026 01:29 UTC